Arrowstreet Capital’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-34,225
Closed -$382K 2517
2020
Q3
$382K Buy
34,225
+6,483
+23% +$72.4K ﹤0.01% 2087
2020
Q2
$375K Buy
+27,742
New +$375K ﹤0.01% 2044